We are live on
!
Find out more
SAGE
Sage Therapeutics
SAGE
SAGE
Delisted
SAGE was delisted on the 30th of July, 2025.
216 hedge funds and large institutions have $2.25B invested in Sage Therapeutics in 2020 Q2 according to their latest regulatory filings, with 46 funds opening new positions, 84 increasing their positions, 55 reducing their positions, and 57 closing their positions.
New
Increased
Maintained
Reduced
Closed
53% more repeat investments, than reductions
Existing positions increased: 84 | Existing positions reduced: 55
39% more call options, than puts
Call options by funds: $30.5M | Put options by funds: $21.9M
39% more capital invested
Capital invested by funds: $1.62B → $2.25B (+$629M)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
4.37% less ownership
Funds ownership: 108.42% → 104.05% (-4.4%)
6% less funds holding
Funds holding: 229 → 216 (-13)
19% less first-time investments, than exits
New positions opened: 46 | Existing positions closed: 57
Holders
216
Holders Change
-13
Holders Change %
-5.68%
% of All Funds
4.43%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
46
Increased
84
Reduced
55
Closed
57
Calls
$30.5M
Puts
$21.9M
Net Calls
+$8.54M
Net Calls Change
+$7.53M
Top Buyers
| 1 |
D.E. Shaw & Co
New York
|
+$62M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$41.9M |
| 3 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$19.1M |
| 4 |
BCLSI
Bain Capital Life Sciences Investors
Boston,
Massachusetts
|
+$18.1M |
| 5 |
BlackRock
New York
|
+$15.9M |
